Group B Streptococcus GBS Diagnosis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Group B Streptococcus (GBS) Diagnosis Market is segmented By Diagnostic Method (Culture Test, PCR Te...

Group B Streptococcus GBS Diagnosis Market Size

Market Size in USD Bn

CAGR5.4%

Study Period2024 - 2031
Base Year of Estimation2023
CAGR5.4%
Market ConcentrationMedium
Major PlayersPfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc, Sanofi and Among Others
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Group B Streptococcus GBS Diagnosis Market Analysis

The group B streptococcus (GBS) diagnosis market is estimated to be valued at USD 1.58 billion in 2024 and is expected to reach USD 2.28 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031. Rapid advancements in screening technologies and growing awareness about GBS infections during pregnancy are expected to drive the group B streptococcus (GBS) diagnosis market during the forecast period.

Group B Streptococcus GBS Diagnosis Market Report Snapshots

Group B Streptococcus GBS Diagnosis Market Size